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ABSTRACT 27 
Lunasin is a peptide with proven properties against cancer and cardiovascular diseases. 28 
Relevant amounts of lunasin have been found in liver of rats fed lunasin-enriched diets, 29 
indicating its potential bioactive effect in this tissue. This study investigated the stability of 30 
lunasin in human liver HepG2 cells, and its chemoprotective effect against oxidative stress 31 
induced by tert-butylhydroperoxide. Cell viability and biomarkers of redox status were 32 
evaluated. Pre-treatment of cells with lunasin (0.5-10 M) significantly prevented the 33 
increased reactive oxygen species (ROS) generation (122% compared to 190% in stressed 34 
cells), and glutathione peroxidase and catalase activities, as well as the depletion of reduced 35 
glutathione. By restraining ROS overproduction, lunasin evoked a decline in carbonyl groups, 36 
and a significant recovery from cell death by apoptosis. These findings suggest that lunasin, at 37 
physiological concentrations, might confer a significant chemoprotection against oxidative 38 
stress-associated liver disorders. In addition, fragments released after hydrolysis of lunasin by 39 
cell enzymes might contribute on the observed antioxidant effects.  40 
 41 
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1. INTRODUCTION 46 
Cells are naturally provided with an extensive array of protective enzymatic and non-47 
enzymatic antioxidants that counteract the potentially injurious oxidizing agents. But even 48 
this multifunctional protective system cannot completely prevent the deleterious effects of 49 
reactive oxygen species (ROS), and consequently, molecules damaged by oxidation 50 
accumulate in cells. Large amounts of ROS have been shown to participate in the 51 
pathogenesis of several human degenerative diseases, including inflammation, cardiovascular 52 
and neurodegenerative disorders, and cancer (Ramos, 2008).
 
Restoration or activation of 53 
improperly working or repressed antioxidant machinery as well as suppression of abnormally 54 
amplified inflammatory signalling can provide important strategies for chemoprevention. 55 
Therefore, determination of anti-inflammatory and/or antioxidant properties has been 56 
proposed as a good indicator for screening anti-cancer agents (Federico, Morgillo, Tuccillo, 57 
Clardiello, & Loguercio, 2007).
 
58 
There is substantial evidence that antioxidant food components have a protective role 59 
against oxidative stress-induced atherosclerosis, degenerative and age-related diseases, cancer 60 
and aging.
1
 Food-derived peptides are promising natural antioxidants without marked adverse 61 
effects. In addition to their potential as safer alternatives to synthetic antioxidants used to 62 
avoid or retard oxidation reactions in foods, antioxidant peptides can also act reducing the risk 63 
of numerous oxidative stress-associated disorders (Meisel, 2004). Lunasin is a 43-amino acid 64 
peptide identified in soybean and other seeds and plants which chemopreventive properties 65 
have been recently reviewed (Hernández-Ledesma, Hsieh, & de Lumen, 2013). This peptide 66 
has demonstrated, by using cell cultures and animal models, to act as anticarcinogenic agent 67 
against skin, prostate, colon, and breast cancer (Hernández-Ledesma, de Lumen, & Hsieh, 68 
2013). Recently, lunasin has been commercialized in the US by its benefits on cardiovascular 69 
system through reduction of low density lipoprotein cholesterol concentration (Gálvez, 2012). 70 
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Moreover, its promising anti-inflammatory and antioxidant activities reported in the recent 71 
years might contribute on lunasin chemoprotective action.
 
Lunasin has been shown to inhibit 72 
inflammation in cultured RAW 264.7 macrophages through suppression of nuclear factor 73 
(NF)- B pathway (González de Mejia, & Dia, 2009; Hernández-Ledesma, Hsieh, & de 74 
Lumen, 2009a; Cam, Sivaguru, & González de Mejia, 2013).
 
Additionally, in vitro assays 75 
have revealed the ability of this peptide to scavenge peroxyl radicals, and to block Fenton 76 
reaction by chelating iron ferrous ions, protecting DNA from oxidative damage (Hernández-77 
Ledesma et al., 2009a; Jeong, de Lumen, & Jeong, 2010; García-Nebot, Recio, & Hernández-78 
Ledesma, 2014).
 
 79 
Studies on bioavailability carried out in mice and rats have demonstrated that, after its oral 80 
ingestion, lunasin appears in an intact and active form in different organs and tissues, such as 81 
blood, liver, and kidney, among others (Jeong, Lee, Jeong, Park, Cheong, & de Lumen, 2009; 82 
Hsieh, Hernández-Ledesma, Jeong, Park, & de Lumen, 2010). In humans, presence of lunasin 83 
has been also reported in plasma, indicating that this peptide might reach different target 84 
tissues, and exert its biological activity (Dia, Torres, de Lumen, Erdman, & González de 85 
Mejia, 2009).  86 
The liver is particularly susceptible to toxic and oxidative insults since the portal vein 87 
brings blood to this organ after intestinal absorption. Therefore, studies dealing with the 88 
effects of chemopreventive compounds at a cellular level in cultured hepatic cells are 89 
essential. Human HepG2, a well differentiated transformed cell line, is a reliable model for 90 
cultured hepatocyte-type cells used for biochemical, pharmacological and nutritional studies 91 
since it retain hepatocyte morphology and most of its functionality in culture (Alía, Ramos, 92 
Mateos, Bravo, & Goya, 2006; Mateos, Goya, & Bravo, 2006).  93 
The aims of the study were to evaluate the stability of lunasin in human liver HepG2 cells 94 
as a model for cultured hepatocytes, and to investigate the potential chemo-protective effect 95 
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of this peptide against oxidative stress chemically induced by a potent pro-oxidant, tert-butyl 96 
hydroperoxide (t-BOOH). Cell integrity and several biomarkers of oxidative damage were 97 
evaluated to estimate the effect of lunasin on cell survival and on the response of the 98 
antioxidant defence systems of HepG2 cells to t-BOOH.  99 
 100 
2. MATERIALS AND METHODS 101 
2.1. Reagents  102 
Peptide lunasin (>95% of purity) was synthesized by Chengdu KaiJie Biopharm Co., Ltd 103 
(Chengdu, Sichuan, P. R. China). t-BOOH, glutathione reductase, reduced glutathione (GSH), 104 
nicotine adenine dinucleotide phosphate reduced salt (NADPH), o-phthalaldehyde (OPT), 105 
dichlorofluorescin (DCFH), dinitrophenylhydrazine (DNPH), trifluoroacetic acid (TFA), 106 
ethylenediaminetetraacetic acid (EDTA), -mercaptoethanol, gentamicin, penicillin G, 107 
streptomycin, Triton-X100, 4-(2-hydroxyethyl)piperazine-1-ethanesulfonic acid (HEPES) and 108 
dithiothreitol (DTT) were purchased from Sigma Chemical Co. (Madrid, Spain). Sodium 109 
dodecyl sulphate (SDS) was from Panreac Química (Madrid, Spain). N-acetyl-Asp-Glu-Val-110 
Asp-7-amino-4-methylcoumarin (Ac-DEVD-AMC) was from BD Pharmigen (Madrid, 111 
Spain). Bradford reagent was from BioRad Laboratories S.A. (Madrid, Spain). The rest of 112 
chemicals used were of HPLC grade.   113 
 114 
2.2. Cell culture  115 
Human HepG2 cells were grown in a humidified incubator containing 5% CO2 and 95% 116 
air at 37ºC. They were grown in Dulbecco's Modified Eagle Medium (DMEM)-F12 medium 117 
from Biowhitaker (Lonza, Madrid, Spain), supplemented with 2.5% (v/v) Biowhitaker foetal 118 
bovine serum (FBS) and 50 mg/L of each of the following antibiotics: gentamicin, penicillin 119 
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G, and streptomycin. Cells were changed to FBS-free medium the day before the assay 120 
(Mateos et al., 2006).
 
121 
 122 
2.3. Cell treatment conditions 123 
Cells were incubated for 20 h with peptide lunasin dissolved in FBS-free DMEM-F12 at 124 
final concentrations ranging from 0.5 to 10 M. To evaluate both direct and protective effects 125 
against oxidative stress, the incubation period was followed by a 3 h treatment with culture 126 
medium (direct effect) or oxidant chemical t-BOOH (400 M). Crystal violet (CV) staining, 127 
GSH concentration, ROS generation and glutathione peroxidase (GPx) and catalase (CAT) 128 
activities were evaluated in both direct and protective experiments. Besides, the protective 129 
effect of lunasin against t-BOOH-induced oxidative damage to proteins and apoptotic cellular 130 
signals was evaluated by carbonyl groups and caspase-3 assays, respectively.  131 
 132 
2.3.1. Crystal violet assay 133 
Cell viability was evaluated following the CV assay described by Granado-Serrano and 134 
co-workers (Granado-Serrano, Martín, Izquierdo-Pulido, Goya, Bravo, & Ramos, 2007). 135 
HepG2 cells were seeded in 96-well plates (1 × 10
4
 cells per well) and incubated overnight. 136 
Then, cells were treated with lunasin for 20 h as described above, washed with PBS, and 137 
incubated with CV (0.2% in ethanol) for 20 min at room temperature. Finally, cell lysis was 138 
carried out with 1% SDS, and the absorbance was read at 570 nm in a microplate reader 139 
(FL600, Bio-Tek, Winooski, VT, USA). Results were pooled from different plates to obtain 140 
average of n = 12, and presented as percentage of viable cells compared to control, considered 141 
as 100%.  142 
 143 
 144 
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2.3.2. Morphological analysis 145 
HepG2 cells were exposed to increasing concentrations (0.5-10 M) of lunasin for 20 h, 146 
then treated with DMEM (controls) or DMEM supplemented with t-BOOH for 3 h, and cell 147 
images were taken using an inverted phase contrast microscope at 20 × magnification. 148 
 149 
2.3.3. Determination of intracellular ROS levels  150 
Intracellular ROS levels were quantified following the method described by Alía and co-151 
workers,
 
using DCFH as fluorescent probe (Alía, Ramos, Mateos, Bravo, & Goya, 2005). 152 
HepG2 were cultured in 24-wells multiwell plates (2 × 10
5
 cells per well), incubated 153 
overnight, and then, treated with lunasin as described above. After 19.5 h incubation with the 154 
peptide, a solution of DCFH was added to each well (5 M final concentration), and cells 155 
were incubated in the dark for 30 min at 37ºC. Afterwards, cells were washed with PBS, 156 
incubated with culture medium (direct effects), or subjected to chemical-induced oxidative 157 
stress with t-BOOH (protective effects). The production of intracellular ROS was followed 158 
over 3 h measuring the fluorescence intensity at excitation and emission of 485 nm and 530 nm, 159 
respectively, in a microplate reader (FL600, Bio-Tek). The results were pooled from different 160 
plates to obtain average of n = 8, and expressed as percentage of the control (cells in a basal 161 
state), considered as 100%.  162 
 163 
2.3.4. Quantification of concentration of GSH and determination of GPx and CAT activity  164 
Cells were seeded onto 100-mm Petri dishes, incubated overnight, treated with lunasin 165 
(for both direct and protective assays), exposed to t-BOOH (for protective assays), and then, 166 
collected following the methodology described by Quéguineur and co-workers (Quéguineur, 167 
Goya, Ramos, Martín, Mateos, & Bravo, 2012). The obtained supernatants, corresponding to 168 
the cellular content of HepG2 cells, were subjected to the determination of the concentration 169 
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of GSH and the activity of GPx and CAT enzymes. The content of GSH was evaluated by a 170 
fluorometric assay as previously described (Quéguineur et al., 2012).
 
Briefly, 50 L of each 171 
sample were transferred in triplicate to a 96-multiwell plate, and the reaction mixture 172 
containing 15 L of 1 M NaOH, 175 L of PBS/EDTA, and 10 L of a solution of OPT (10 173 
mg/mL) was added. After 20 min incubation, the fluorescence was read ( excitation/ emission = 174 
340/460 nm) in a microplate reader (FL600, Bio-Tek). Results were pooled from different 175 
plates to obtain average of n = 6, and interpreted considering those of a standard GSH curve 176 
similarly prepared within each of the experiments run.
 
177 
GPx catalyses the oxidation of GSH to oxidized glutathione, using t-BOOH as a substrate, 178 
reaction coupled to the decomposition of NADPH to -nicotinamide adenine dinucleotide by 179 
glutathione reductase. Thus, disappearance of NADPH reliably estimates GPx activity, which 180 
can be measured by following the decrease in absorbance at 340 nm (Alía et al., 2006). CAT 181 
activity was determined by following the breakdown of the peroxide H2O2 to H2O, monitored 182 
as a decrease in absorbance at 240 nm (Granado-Serrano et al., 2007). Results for both GPx 183 
and CAT activities were pooled from different plates to obtain average of n = 6, and 4, 184 
respectively, and referred to the total protein concentration of the cytosolic samples, measured 185 
by the Bradford reagent (Bio-Rad). 186 
 187 
2.3.5. Evaluation of carbonyl groups 188 
Oxidative damage to proteins by reactive species, particularly ROS, was evaluated by 189 
measuring the content of carbonyl groups in cell supernatants according to the method of 190 
Richert and co-workers (Richert, Wehr, Stadtman, & Levine, 2002). Absorbance was 191 
measured at 360 nm, and carbonyl content results (experiments run to obtain an average of n 192 
= 4) were expressed as nmol of carbonyl groups per mg of total protein, using an extinction 193 
coefficient of 22000 nmol/L/cm.  194 
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2.3.6. Determination of caspase-3 activity 195 
Caspase-3 activity was measured according to the fluorometric assay previously described 196 
(Herrera et al., 2001). After treatment with lunasin for 20 h and chemical induction with t-197 
BOOH for 3 h, cells were collected, and lysed in a buffer containing 5 mM Tris, 20 mM 198 
EDTA, and 0.5% Triton-X100. Then, the reaction mix containing 30 g cell protein, 20 mM 199 
HEPES, 10% glycerol, 2 mM DTT, and 20 M Ac-DEVD-AMC was incubated in the dark 200 
for 2 h. Fluorescence was measured at excitation and emission of 380 nm and 440 nm, 201 
respectively, in a microplate reader (FL600, Bio-Tek), and enzymatic activity results 202 
(experiments run to obtain an average of n = 4) were expressed as units of caspase-3 per g of 203 
total protein.  204 
 205 
2.4. Stability of lunasin 206 
HepG2 cells were plated in 60 mm-diameter plates at a density of 1.5 × 10
6 
cells per plate, 207 
and incubated at 37ºC overnight. Then, cells were treated with 10 M lunasin dissolved in 208 
FBS free DMEM-F12, and incubated at 37ºC for 20 h, taking aliquots of the medium at 0, 2, 209 
6, 12, and 20 h of incubation. These aliquots were subjected to liquid chromatography 210 
(HPLC) coupled to tandem mass spectrometry (HPLC-MS/MS) on an Agilent 1100 HPLC 211 
System (Agilent Technologies, Waldbron, Germany) connected on-line to an Esquire 3000 212 
ion trap (Bruker Daltonik GmbH, Bremen, Germany), and equipped with an electrospray 213 
ionization source as previously described (Contreras, Gómez-Sala, Martín-Álvarez, Amigo, 214 
Ramos, & Recio, 2010). The column used was a Mediterranea Sea18 (150 x 2.1 mm, 215 
Teknokroma, Barcelona, Spain), the injection volume was 50 L, and the flow was set at 0.2 216 
mL/min. Peptides were eluted with a linear gradient of solvent B (acetonitrile:TFA 1000:0.27 217 
v/v) in A (water:TFA 1000:0.37 v/v) going from 0% to 45% in 130 min. Data obtained were 218 
processed and transformed to spectra representing mass values using the Data Analysis 219 
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program (version 4.0, Bruker Daltonik). To process the MS/MS spectra and to perform 220 
peptide sequencing BioTools (version 3.1, Bruker Daltonik) was used. 221 
 222 
2.5. Statistics  223 
Data were analyzed by a one-way ANOVA followed by the Bonferroni Multiple 224 
Comparison test, and expressed as the mean ± standard variation (SD). GraphPad Prism 5.0 225 
software (San Diego, CA, USA) was used to perform statistical analyses. Differences with a P 226 
value < 0.05 (*,
#
), P value < 0.01 (**,
##
) or P value < 0.001 (***,
###
) were considered 227 
significant.  228 
 229 
3. RESULTS AND DISCUSSION 230 
3.1. Chemoprotective effects of lunasin on cell viability and redox status  231 
In order to evaluate the effect of lunasin at physiological level, in the present study, a 232 
range of concentrations between 0.5 to 10 M was selected. Previous studies on lunasin’s 233 
bioavailability have demonstrated that, because of the protection against gastric and 234 
pancreatic enzymes exerted by naturally occurring protease inhibitors such as the Bowman-235 
Birk inhibitor (BBI), a high percentage of daily ingested peptide remains intact during its 236 
passage through gastrointestinal tract, reaching target organs and tissues in an active form 237 
(Hsieh et al., 2010). The presence of lunasin and BBI has been confirmed in different soybean 238 
products, such as soymilk, tofu, soybean cake and fermented soybean products (Hernández-239 
Ledesma, Hsieh, & de Lumen, 2009b). Daily consumption of 25 g of soy protein, 240 
recommended by Food and Drug Administration (FDA) to reduce coronary disease (FDA, 241 
1999), supplies lunasin in quantity ranged from 110 mg (21.9 mol) to 1760 mg (350.2 242 
mol). Selected concentrations in our study were not far from reality since steady-state 243 
concentrations of 99.3 g/g tissue were isolated from liver of rats fed lunasin-enriched rye 244 
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diets for 4 weeks, and lunasin extracted from those livers has been demonstrated to be active 245 
(Jeong et al., 2009).  246 
Before testing the chemo-protective effect of lunasin, it was important to evaluate the 247 
effect of this peptide per se, in basal conditions, ensuring that no direct damage is caused to 248 
the cell by the compound. Thus, the direct effect of lunasin on HepG2 cells viability was 249 
evaluated. The CV assay, based on the growth rate reduction reflected by the colorimetric 250 
determination of the stained cells, was used to determine the cell viability. As shown in 251 
Figure 1A, treatment of HepG2 cells with lunasin for 20 h evoked no decreases in CV 252 
staining, indicating that the concentrations selected for the study (0.5-10 M) did not damage 253 
cell integrity during the period of incubation. Higher concentrations of lunasin were also 254 
assessed, observing that the percentage of viable cells were not affected by 25 M lunasin 255 
(111.20% ± 4.80) and 50 M lunasin (111.07% ± 6.19).  256 
Because of its connection to the gastrointestinal tract and its unique metabolic activity, 257 
the liver is one of the main body targets of the toxicity of drugs, xenobiotics, environmental 258 
contaminants, as well as oxidative stress (Jaeschke, Gores, Cederbaum, Hinson, Pessayre, & 259 
Lemasters, 2002). The cell damage caused by ROS and other reactive species plays a crucial 260 
role in the induction and progression of several liver diseases such as hepatocarcinoma, viral 261 
and alcoholic hepatitis, and non-alcoholic steatosis.
 
Consequently, there is an increasing 262 
interest in new therapeutic agents protecting liver from such oxidative damage, with natural 263 
antioxidants being considered one of the most effective alternatives (Vitaglione, Morisco, 264 
Caporaso, & Fogliano, 2004). t-BOOH, a short-chain analog of lipid peroxide, is often used to 265 
induce acute oxidative stress in different in vitro and in vivo systems, and to evaluate the 266 
protective effects of antioxidants (Mersch-Sundermann, Knasmuller, Wu, Darroudi, & Kassie, 267 
2004). In the case of hepatocytes, these cells metabolize t-BOOH to toxic peroxyl and alkoxyl 268 
radicals, initiating peroxidation of macromolecules, and thus, affecting the cell integrity and 269 
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leading to chemical-induced hepatic oxidative damage. Therefore, treatment of HepG2 cells 270 
with t-BOOH is an excellent model of oxidative stress in cell culture systems (Alía et al., 271 
2005). To evaluate whether lunasin protects HepG2 from oxidative stress induced by t-272 
BOOH, we first determined its effects on the cell viability. As shown in Figure 1A, the 273 
percentage of viable cells in HepG2 induced by 400 M t-BOOH was 67.5% (compared to 274 
non-stressed cells), indicating that this chemical showed remarkable cytotoxicity (P < 0.001) 275 
on these cells. However, incubation of the cells with 0.5-10 M lunasin for 20 h, prior to 276 
chemical oxidant treatment, significantly restored cell viability up to 99.8% (P < 0.001), 277 
although dose-dependent effects were not observed.  278 
As shown in Figure 2A and 2B, HepG2 cells treated with t-BOOH showed reduction 279 
in cell numbers and loss of cell-to-cell contact. These morphological changes in t-BOOH-280 
induced HepG2 cells were attenuated by pre-treatment with lunasin at 0.5 M (Figure 2C), 281 
and 5 M (Figure 2D). 282 
As shown in Figure 2A, 2B, morphological changes in HepG2 cells due to the toxic effect of 283 
t-BOOH were clearly visible. However, such changes were reduced by lunasin at 0.5 M 284 
(Figure 2C), and 5 M (Figure 2D). 285 
 In order to understand whether the cytoprotective effect of lunasin might be attributed 286 
to the reduction of oxidative stress, the intracellular ROS generation was evaluated in HepG2 287 
exposed to t-BOOH with and without pre-treatment with lunasin for 20 h. As shown in Figure 288 
1B, the level of intracellular ROS in HepG2 cells treated with t-BOOH alone was 190.0% 289 
compared to the non-treated cells (considered as 100%), indicating that 400 M t-BOOH had 290 
a strong effect on ROS generation. When the cells were pre-treated with lunasin, intracellular 291 
ROS levels were significantly decreased up to 122% (compared to control) (P < 0.001), but 292 
no dose-dependent activity was observed. These results suggest that ROS generated during 293 
the period of oxidative stress were more efficiently quenched in cells pre-treated 20 h with 294 
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lunasin, which could be a first explanation for the reduced cell damage and death shown. The 295 
intracellular ROS levels of non-stressed cells were also decreased by treatment with lunasin, 296 
reaching 63.6% (compared to control cells) when 5 M lunasin was used (Figure 1B). These 297 
findings confirm the ability of this peptide as an effective scavenger of ROS in cell cultures. 298 
Previous studies have demonstrated that lunasin is a potent antioxidant in different in vitro 299 
assays, including reducing power, and ABTS, peroxyl and superoxide radical scavenging 300 
activity (Hernández-Ledesma et al., 2009a; Jeong et al., 2010; García-Nebot et al., 2014).  301 
Lunasin at concentrations higher than 1 M significantly increased the cytosolic levels of 302 
GSH (P < 0.05) (Figure 1C). GSH is a tripeptide found in all mammalian cells and considered 303 
the main non-enzymatic antioxidant defense within the cell. It appears in high concentration 304 
in the liver where plays a crucial role protecting against oxidative stress through elimination 305 
of toxic ROS, and mitigation of macromolecules peroxidation and cell injury (Mari, Morales, 306 
Colell, García-Ruiz, & Fernández-Checa, 2009). It is usually assumed that enhanced levels of 307 
GSH prepare the hepatocytes against a potential oxidative insult, whereas its depletion 308 
reflects an intracellular oxidation state (Alía et al., 2005). The effect of lunasin on GSH 309 
levels, together the decreased ROS generation, reflects a diminished intracellular oxidation 310 
which could be expected to place the cell in favourable conditions to face a potential oxidative 311 
insult. In addition to its effect as inducer of ROS generation, t-BOOH also provokes GSH 312 
depletion (Goya, Mateos, & Bravo, 2007). GSH is a tripeptide found in all mammalian cells 313 
and considered the main non-enzymatic antioxidant defense within the cell. It appears in high 314 
concentration in the liver where plays a crucial role protecting against oxidative stress through 315 
elimination of toxic ROS, and mitigation of macromolecules peroxidation and cell injury 316 
(Mari, Morales, Colell, García-Ruiz, & Fernández-Checa, 2009). It is usually assumed that 317 
enhanced levels of GSH prepare the hepatocytes against a potential oxidative insult, whereas 318 
its depletion reflects an intracellular oxidation state (Alía et al., 2005).
 
Lunasin at 319 
 14 
concentrations higher than 1 M significantly increased the cytosolic levels of GSH (P < 320 
0.05) (Figure 1C). This result, together the decreased ROS generation, reflects a diminished 321 
intracellular oxidation which could be expected to place the cell in favourable conditions to 322 
face a potential oxidative insult. As it is demonstrated in the present study, tTreatment of 323 
HepG2 cells with t-BOOH induced a significant decrease in the concentration of GSH (P < 324 
0.001), as it was previously demonstrated (Goya, Mateos, & Bravo, 2007). However, this 325 
depletion of the GSH store was partly prevented by pre-treatment with lunasin (Figure 1C). 326 
These findings indicate that increased levels of GSH in the lunasin-treated cells before 327 
exposure to the oxidative damage greatly helped to prevent the dramatic depletion of 328 
intracellular GSH during the oxidative stress, an effect of lunasin that had not been reported 329 
previously. Maintaining GSH concentration above a critical threshold while facing a stressful 330 
situation represents an enormous advantage for cell survival.  331 
 332 
3.2. Influence of lunasin on antioxidant enzymes activity 333 
In order to investigate whether the antioxidant properties of lunasin are related to the 334 
induction of the antioxidant enzymes activity, HepG2 cells were treated with this peptide, and 335 
the activity of enzymes GPx and CAT was measured. In non-stressed HepG2 cells, lunasin 336 
did not provoke any change in the activity of GPx and CAT (data not shown). These results 337 
indicate that in spite of the direct effects of lunasin on ROS levels and GSH content, the 338 
defence enzymatic system in the cells was balanced. The increase in the activity of GPx and 339 
CAT observed after exposure to t-BOOH (Figure 3A and 3B), clearly indicates a positive 340 
response of the cell defense system to face the increasing generation of ROS evoked by the 341 
oxidative insult (Alía et al., 2006; Goya, Martín, Ramos, Mateos, & Bravo, 2009). It has been 342 
demonstrated that GPx and CAT These enzymes play a crucial role as the first line of the 343 
antioxidant defense system against ROS generated during oxidative stress (Ray & Husain, 344 
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2002). GPx catalyses reduction of H2O2 or other peroxides at the expense of GSH oxidation to 345 
oxidized glutathione, and CAT converts H2O2 to H2O. Both enzyme activities are thus 346 
essential for the intracellular quenching of cell-damaging peroxide species but by two distinct 347 
mechanisms, since GPx is a glutathione-related enzyme whereas CAT is independent from 348 
glutathione (Goya, Martín, Ramos, Mateos, & Bravo, 2009). However, a rapid return of the 349 
antioxidant enzyme activities to basal values once the challenge has been surmounted will 350 
place the cell in a favorable condition to deal with a new insult. Therefore, changes in their 351 
activity are considered as biomarkers of the antioxidant cellular response. In non-stressed 352 
HepG2 cells, lunasin did not provoke any change in the activity of GPx and CAT (data not 353 
shown). These results indicate that in spite of the direct effects of lunasin on ROS levels and 354 
GSH content, the defence enzymatic system in the cells was balanced. The increase in the 355 
activity of GPx and CAT observed after exposure to t-BOOH (Figure 3A and 3B), clearly 356 
indicates a positive response of the cell defense system to face the increasing generation of 357 
ROS evoked by the oxidative insult (Alía et al., 2006; Goya et al., 2009). However, a rapid 358 
return of the antioxidant enzyme activities to basal values once the challenge has been 359 
surmounted will place the cell in a favorable condition to deal with a new insult. It has been 360 
previously shown that flavonoid quercetin (Alía et al., 2006), olive oil phenol hydroxytyrosol 361 
(Goya et al., 2007), organic selenium derivatives (Cuello et al., 2007), and seaweed 362 
metabolite phloroglucinol (Quéguineur et al., 2012), among others, protect HepG2 cell 363 
integrity by preventing the severely increased activity of antioxidant enzymes induced by t-364 
BOOH. In the present study, we show, for the first time, that a 20 h treatment of human 365 
HepG2 cells with lunasin prevents the permanent increase in the activity of both glutathione-366 
related GPx and glutathione-independent CAT induced by oxidative stress (Figure 3A and 367 
3B). Thus, the restrained ROS production during the stressful challenge in lunasin-treated 368 
HepG2 cells reduces the need of peroxide detoxification through GPx and CAT. Although a 369 
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potential direct effect of lunasin on antioxidant enzymes gene expression throughout the 370 
antioxidant response element cannot be ruled out, the protective mechanism of lunasin can be 371 
illustrated in terms of regulation of the specific activity of antioxidant defence enzymes. 372 
 373 
3.3. Lunasin-induced reduction of protein oxidation 374 
Since protein carbonyl concentration has been found elevated in various diseases thought 375 
to be related to free radical damage, it has been widely used as an index of protein oxidation 376 
in biological and medical sciences (Mateos, & Bravo, 2007). Figure 4A shows that 3 h-377 
treatment of HepG2 with 400 µM t-BOOH evoked a significant increase in the cellular 378 
concentration of protein carbonyl groups of about 3-times compared to non-stressed cells, 379 
indicating an intense oxidative damage to cell proteins. However, pre-incubation of the cells 380 
with lunasin at concentrations ranged from 0.5 to 10 µM for 20 h reduced the protein carbonyl 381 
levels down to levels measured in non-stressed cells. This fact indicates the ability of this 382 
peptide to diminish the level of protein oxidation resulting from chemical induction with t-383 
BOOH. Other food compounds including plant polyphenols, beta carotene, lutein, seaweed 384 
metabolite phloroglucinol and biscuit melanoidins have been also reported to prevent protein 385 
oxidation (Alía et al., 2006; Goya et al., 2007; Martín, Ramos, Mateos, Izquierdo-Pulido, 386 
Bravo, & Goya, 2010; Murakami, Hirakawa, Inui, Nakano, & Yoshida, 2002; Quéguineur et 387 
al., 2012).
 
However, to date, no dietary peptide had demonstrated to exert this protective 388 
effect. 389 
  390 
3.4. Lunasin prevents apoptosis by reducing stress-induced caspase-3 391 
Oxidative stress-induced hepatic cell injury results not only from direct chemical 392 
interactions by altering cellular macromolecules such as DNA, proteins and lipids, but also 393 
from alterations in key mediators of stress signals and stress-dependent apoptosis reactions 394 
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(Singh, & Czaja, 2008). In this regard, ROS generation has been described as a critical 395 
upstream activator of the caspase cascade that ends up with stimulation of downstream key 396 
effectors such as caspase-3 and subsequent development of apoptosis (Singh, & Czaja, 2008). 397 
Besides, GSH depletion is a common feature of apoptotic cells, and its role as a critical 398 
regulator in the signaling pathways leading to the progression of apoptosis has been reported 399 
(Franco, & Cidlowski, 2009, 2012). As shown in Figure 4B, the caspase-3 activity was 400 
significantly increased after 400 M t-BOOH treatment for 3 h (P < 0.001), compared with 401 
the non-stressed cells. Previous studies had also demonstrated this pro-apoptotic effect of 402 
chemical t-BOOH on HepG2 cells through activation of caspase-3 and, ultimately, cell death 403 
(Martín, Granado-Serrano, Ramos, Izquierdo-Pulido, Bravo, & Goya, 2010). Consistent with 404 
the above mentioned ROS scavenging effect of lunasin, this peptide in the range of 1-10 M 405 
effectively reduced caspase-3 activity in t-BOOH-induced HepG2 cells (P < 0.001) although 406 
no dose-response was observed, indicating that increases in lunasin’s concentration did not 407 
improved the caspase-3 activity reduction caused by this peptide. The demonstrated effects 408 
indicated the preventive capacity of lunasin against  preventing the apoptotic effects induced 409 
by disruption of the redox steady-state.  410 
 411 
3.5. Stability of peptide lunasin in HepG2 cultures  412 
In order to study the stability of lunasin after its addition to HepG2 cells and incubation 413 
for 20 h, the medium without and with lunasin (10 M) at different incubation hours (0, 2, 6, 414 
12, and 20 h) was analyzed by HPLC-MS/MS. As an example, Figure 5 shows the extracted 415 
ion chromatograms of the molecular ion of lunasin m/z 1257.5 (charge +4)
 
obtained after 6, 416 
12, and 20 h-incubation of cells with lunasin. The lunasin’s peak area was measured (Figure 417 
6), and it was observed that the content of this peptide in the medium notably decreased with 418 
the incubation time. After 12 h-incubation, only 29% of initial lunasin remained in the 419 
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medium, and after 20 h, less than 1% was visibleobservable. In the present study, the analysis 420 
by HPLC-MS/MS also allowed the identification of lunasin-derived fragments that could be 421 
released during incubation of lunasin with HepG2 cells (Figure 5). Five lunasin-fragments 422 
were observed; all of them corresponding to the C-terminal region of the peptide, from the 423 
amino acid residue 25. The identified peptides’ peak areas were also measured (Figure 6). 424 
After 2 h-incubation, fragments f(25-43) and f(26-43) were already visibledetectable in the 425 
medium. Other three peptides were released at 6 and 12 h-incubation. It has to be highlighted 426 
that after 20 h, extracellular lunasin only represented the 0.6% of total identified peptides 427 
whereas peptide f(25-43) represented 76.5%. Therefore, it can be postulated that the most 428 
abundant fragment, f(25-43), can be, at least, in part, responsible of the activity observed, and 429 
further studies with this lunasin-derived peptide are already in progress. In spite the important 430 
hydrolysis observed, it cannot be excluded that part of the lunasin could also internalize into 431 
HepG2 cells. It is also important to note that all the identified fragments contain the C-432 
terminal part of the lunasin, which had previously been proposed as the active site of lunasin 433 
(Hernández-Ledesma et al., 2013). The hydrolysis of lunasin observed in contact with the 434 
HepG2 cells was different to that observed in our previous study with differentiated human 435 
intestinal Caco-2 cells (García-Nebot et al., 2014), where most of lunasin added to culture 436 
medium remained intact after 24 h incubation with these cells. 437 
In the present study, analyses, focused on evaluating the antioxidant activity of peptide 438 
lunasin in HepG2 cells, were carried out after 20 h pre-treatment with this peptide. It was 439 
demonstrated the protective mechanism on cells submitted to an oxidative stress that can be 440 
illustrated in terms of regulation of the cellular redox status, i.e. peptide treatment restrained 441 
ROS production and maintained GSH concentration during the stress which reduced the 442 
necessity of peroxide detoxification through GPx and CAT. Additionally, a controlled ROS 443 
generation reduced oxidative damage to proteins and restrained activity of the apoptotic 444 
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pathway resulting in improved cell viability. The final findings found on lunasin’s stability in 445 
HepG2 cells indicated that this peptide was markedly hydrolyzed at the selected time (20 h), 446 
and thus, in addition to the remaining peptide, the fragments released during its hydrolysis 447 
might be the actual responsible for the observed effects. All the peptides identified at 20 h 448 
corresponded to the active site sequence of lunasin described to date. Also, they contained the 449 
motif RGD known to be crucial for the interaction of proteins or peptides with its cell surface 450 
receptor (Ruoslahti, & Pierschbacher, 1986). Therefore, these structural characteristics make 451 
these five peptides promising chemo-protective peptides against oxidative stress in liver 452 
HepG2 cells. In conclusion, our results point out for the first time a direct antioxidant action 453 
of lunasin or its derived fragments on hepatocytes exposed to oxidizing species. It indicates 454 
the possibility that these peptides may significantly contribute to preserve the integrity of liver 455 
tissues against oxidative damage related disorders. Since this study has been carried out with 456 
synthetic lunasin which secondary and tertiary structure could differ to that of plant-purified 457 
lunasin, confirmation of the effects should be needed to demonstrate the chemo-protective 458 
potential of natural lunasin. 459 
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FIGURE CAPTIONS 588 
Figure 1. Direct and protective effects of peptide lunasin on cell viability and intracellular 589 
ROS and GSH levels. HepG2 cells were pre-incubated with medium or medium 590 
supplemented with lunasin (final concentration ranged from 0.5 to 10 M) for 20 h before 591 
treatment with medium (□: non-stressed cells) or medium supplemented with 400 M t-592 
BOOH for 3 h (■). (A) Cell viability was measured by the CV assay. Results are expressed as 593 
percent of viable cells, n = 12. (B) Intracellular ROS generation. Fluorescence units 594 
corresponding to intracellular ROS production are expressed as percent of data from non-595 
stressed cells, n = 8. (C) Intracellular GSH levels. Results of fluorescent analysis are 596 
calculated as nmoles of GSH per mg of protein, and represented as percentage of non-stressed 597 
cells, n = 6. 
*
(P < 0.05), 
***
(P < 0.001), significantly different from control non-stressed cells, 598 
and 
###
(P < 0.001), significantly different from control t-BOOH-induced cells. 599 
 600 
Figure 2. Morphological analysis of HepG2 cells. HepG2 cells were pre-incubated with 601 
medium or medium supplemented with lunasin (final concentration 0.5-10 M) for 20 h 602 
before treatment with medium (non-stressed cells) or medium supplemented with 400 M t-603 
BOOH for 3 h. Representative images of (A) non-stressed cells pre-incubated with medium, 604 
(B) t-BOOH-induced cells pre-incubated with medium, and t-BOOH-induced cells pre-605 
incubated with (C) 0.5 M lunasin and (D) 5 M lunasin. HepG2 cells pre-incubated with 606 
medium and treated with t-BOOH showed reduction in cell numbers and loss of cell-to-cell 607 
contact (arrows), compared with non-stressed cells pre-incubated with medium, and t-BOOH-608 
induced cells pre-incubated with lunasin. Size bar: 10 μm. 609 
 610 
Figure 3. Protective effects of lunasin on enzymes GPx and CAT activity. HepG2 cells were 611 
pre-incubated with medium or medium supplemented with lunasin (final concentration ranged 612 
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from 0.5 to 10 M) for 20 h before oxidation induction with 400 M t-BOOH for 3 h (■). 613 
Results of enzymes (A) GPx and (B) CAT activities are calculated as mUnits per mg of 614 
protein and represented as percentage of data from non-stressed cells (□). Represented values 615 
are means ± SD of n = 6 (GPx) and n = 4 (CAT). 
***
(P < 0.001), significantly different from 616 
control non-stressed cells, and 
#
(P < 0.05), 
##
(P < 0.01), 
###
(P < 0.001), significantly different 617 
from control t-BOOH-induced cells. 618 
 619 
Figure 4. Protective effects of lunasin on protein carbonyl content and caspase-3 activity. 620 
HepG2 cells were pre-incubated with medium or medium supplemented with lunasin (final 621 
concentration ranged from 0.5 to 10 M) for 20 h before oxidation induction with 400 M t-622 
BOOH for 3 h (■). (A) Protein carbonyl content. Results are expressed as nmol per mg 623 
protein and represented as percentage of non-stressed cells (□). (B) Caspase-3 activity. 624 
Results are calculated as Units per g of protein and expressed as percent of control data. 625 
Values are means ± SD of 4 different samples per condition. 
***
(P < 0.001), significantly 626 
different from control non-stressed cells, and 
###
(P < 0.001), significantly different from 627 
control t-BOOH-induced cells. 628 
 629 
Figure 5. Stability of peptide lunasin in medium added to HepG2 cells. (A) Extracted ion 630 
chromatogram (EIC) of the molecular ion of lunasin (F1) m/z 1257.5 (charge +4), f(32-43) 631 
(F2) m/z 1324.5 (charge +1), f(30-43) (F3) m/z 1565.5 (charge +1), f(29-43) (F4) m/z 1693.8 632 
(charge +1), f(26-43) (F5) m/z 1034.1 (charge +2), f(25-43) (F6) m/z 1102.7 (charge +2) in 633 
serum free DMEM-F12 medium incubated with 10 M lunasin and collected after (A) 6 h, 634 
(B) 12 h, and (C) 20 h-incubation. Figure 6.(B) Relative amount (expressed as peak area) of 635 
lunasin (F1) and its derived fragments (F2-F6) in serum free DMEM-F12 medium incubated 636 
with lunasin for 0, 2, 6, 12, and 20 h. 637 
